Concepedia

Author

Akito Hisanaga

Chiba University

Also Known As

AKITO HISANAGA, Akito HISANAGA, Akito Hisanaga

23

Publications

252

Citations

8

H-Index

25

Concepts

All Affiliations

Chiba UniversityTohoku UniversityTohoku University HospitalAkita UniversityKeio University
AH

About

Akito Hisanaga is an author at Chiba University specializing in medicine, public health, and clinical epidemiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

47

2

Public Health

2

2

29

3

Epidemiology

1

1

16

4

Hospital Medicine

1

1

16

5

Molecular Medicine

1

1

13

Akito Hisanaga

×

6

Publications

197

Citations

6

H-Index

YearCitations

Multicentre population‐based dementia prevalence survey in Japan: a preliminary report

Chiaki Ikejima, Akito Hisanaga, Kenichi Meguro,

Psychogeriatrics

2012

91

Four cases of panic disorder successfully treated with Kampo (Japanese herbal) medicines: Kami‐shoyo‐san and Hange‐koboku‐to

Naoki Mantani, Akito Hisanaga, Toshiaki Kogure,

Psychiatry and Clinical Neurosciences

2002

49

Multicenter, randomized controlled trial of traditional Japanese medicine, kakkonto with shosaikotokakikyosekko, for mild and moderate coronavirus disease patients

Shin Takayama, Takao Namiki, Ryutaro Arita,

Frontiers in Pharmacology

2022

18

Conventional and Kampo Medicine Treatment for Mild-to-moderate COVID-19: A Multicenter, Retrospective, Observational Study by the Integrative Management in Japan for Epidemic Disease (IMJEDI Study-observation)

Shin Takayama, Tetsuhiro Yoshino, Sayaka Koizumi,

Internal Medicine

2022

16

Identification of a Predictive Biomarker for the Beneficial Effect of Keishibukuryogan, a Kampo (Japanese Traditional) Medicine, on Patients with Climacteric Syndrome

Takao Namiki, Hiromi Sato, Yukari Matsumoto,

Evidence-based Complementary and Alternative Medicine

2014

13

Contribution of traditional Japanese Kampo medicines, kakkonto with shosaikotokakikyosekko, in treating patients with mild-to-moderate coronavirus disease 2019: Further analysis of a multicenter, randomized controlled trial

Shin Takayama, Takao Namiki, Ryutaro Arita,

Journal of Infection and Chemotherapy

2023

10

Page 1